MONOBLUE SafR

MONOBLUE SAFR                   

General Indications

  • Temporary staining of the capsule.
  • Temporary staining of intrastromal corneal tissue.
  • Temorary staining of the Descemet’s membrane.
  • Visualisation of the position of the corneal graft on recipient tissues during keratoplasty.

MONOBLUE SafR 0.055%. Helps in performing capsulorhexis and other uses in the anterior segment, improves tolerance of trypan blue thanks to purification of the raw material and the addition of mannitol.

Improves Tolerance Thanks To Its Purification. To ensure maximum tolerance, the exclusive Arcadophta purification process guarantees the extraction of toxic components such as toludine – violet, and monoazo, thereby improving tolerance of MonoBlue SafR.

Improves Tolerance Thanks To The Addition Of Mannitol. The addition of mannitol, known for its antioxidant properties, combined with the already-purified trypan blue, enhances the tolerance of MonoBlue SafR.

Facilitates Capsulorhexis By Improving Staining. The high percentage of blue >95% in Monoblue SafR enhances its staining power on the capsule, or the tissues of the anterior segment such as Descemet’s membranes, trabeculum, etc.

Facilitates Capsulorhexis Through Its Dedicated Packaging. The use of a long pre-filled syringe and specific plunger guarantees a smooth, controlled injection.

 

 

https://www.bvimedical.com/products/monoblue-safr/

Downloads:

MONOBLUE SAFR